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Abstract
Background: Chronic low-grade inflammation is considered a driver of many age-related disorders, including vascular
diseases (inflammaging). Inhibition of autophagic capacity with ageing was postulated to generate a pro-inflammatory
condition via activation of inflammasomes, a group of Interleukin-1 activating intracellular multi-protein complexes. We
thus investigated gene expression of inflammasome components in PBMC of 77 vascular patients (age 22–82) in
association with age.
Findings: Linear regression of real-time qRT-PCR data revealed a significant positive association of gene expression of
each of the inflammasome components with age (Pearson correlation coefficients: AIM2: r = 0.245; P = 0.032; NLRP3:
r = 0.367; P = 0.001; ASC (PYCARD): r = 0.252; P = 0.027; CASP1: r = 0.296; P = 0.009; CASP5: r = 0.453; P = 0.00003;
IL1B: r = 0.247; P = 0.030). No difference in gene expression of AIM2, NLRP3, ASC CASP1, and CASP5 was detected
between PBMC of patients with advanced atherosclerosis and other vascular patients, whereas IL1B expression was
increased in PBMC of the latter group (P = 0.0005).
Conclusion: The findings reinforce the systemic pro-inflammatory phenotype reported in elderly by demonstrating an
increased phase-1 activation of inflammasomes in PBMC of vascular patients.
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Findings
Background
The concept of inflammaging implies that a low-grade
pro-inflammatory status, predisposing the organism to
chronic diseases, appears during the ageing process [1].
A number of reports have provided experimental evi-
dence for this hypothesis and remodeling of the immune
system was postulated to drive many age-related disor-
ders [2]. In addition, altered function of innate immune
cells, in particular changes in monocytes and macro-
phages, have been described in mice [3] and humans [4].
Clinically, aging is associated with increases of circulat-
ing IL-18 and IL-6 plasma levels, whereas IL-1β is un-
detectable [5, 6].
During aging, injuries, necrotic cell death and meta-
bolic cell stress accumulate thereby increasing the risk
of chronic inflammation [7, 8]. Dead cells and their me-
tabolites are usually cleared by autophagy though macro-
phages. A disturbed interplay between autophagy and the
inflammasomes was recently postulated to link inflamma-
ging with vascular and other pathologies [9]. The inflam-
masomes are a family of multiprotein complexes for
danger signal recognition that are induced by pathogens
or cell debris (damage associated molecular patterns,
DAMPS) [10, 11]. Expression levels of the inflammasome
components are generally low and require a two phase in-
duction: A priming phase stimulates gene expression of
inactive precursors before a second signal can stimulate
assembly of the multiprotein complex consisting of sensor
proteins, the adaptor protein apoptosis-associated speck-
like protein with a caspase activation and recruitment do-
main (ASC) and inflammatory caspases (Caspase-1 or
Caspase-5). Upon assembly, the caspases are enzymati-
cally cleaved by the complex resulting in their active form,
which then stimulates enzymatic cleavage of Interleukin-
1β (IL-1β) and IL-18 from inactive precursors [10].
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Depending on the initial sensor, several subfamilies are
distinguished: The NOD-like receptors (NLR), including
NLRP3 and others, act as sensors for intracellular damage
associated signals such as cholesterol crystals, nanoparti-
cles, reactive oxygen species and others. The DNA sen-
sors, including Absent in Melanoma 2 (AIM2) act as
sensors for intracellular dsDNA [10].
Given the recently demonstrated involvement of inflam-
masome activation in vascular disease [12–14] and its pu-
tative role in inflammaging, we here addressed gene
expression of inflammasome components in PBMC of
vascular patients in association with age.
Materials and methods
Venous blood was taken from 77 vascular patients on the
day of their hospitalization according to the standard op-
erating procedures of the Vascular Biobank Heidelberg
(VBBH). All patients gave their written informed consent
to the study, which was approved by the ethical com-
mittee of the University of Heidelberg (S-301/2013
and S-412/2013). Patients’ characteristics are described in
Additional file 1: Table S1.
PBMC and plasma were separated according to stand-
ard procedures (for details see Additional file 2), RNA ex-
traction and reverse transcription were performed as
described earlier ([13] and Additional file 2). Quantitative
analysis of gene expression was performed by real time
PCR and relative expression was determined by using in-
dividual standard amplification curves of each transcript
relative to the corresponding mean expression of three
reference transcripts (GAPDH plus B2M plus ACTB).
Active, cleaved IL-1β (p17) in plasma was quantified
by ELISA, Caspase-1 protein was detected by Western
blotting (for details see Additional file 2).
Results and discussion
As shown in Fig. 1, best fit regression revealed a close
association of AIM2, NLRP3, ASC, CASP1, CASP5, and
IL1B gene expressions with age of the patients. The
strongest correlation was found for CASP5 with a correl-
ation coefficient of 0.468 (P = 0.00003). Regression coef-
ficients and p-values of the linear regression analysis are
summarized in Table 1.
To examine, whether the increased expression of inflam-
masome components resulted in increased activation of
the inflammasome multiprotein complex, we next deter-
mined the amount of its effector proteins, activated
caspase-1 (p10) and activated Il-1β (p17) . Active IL-1β was
detected in plasma of 3 out of 30 patients with abdominal
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Fig. 1 Best fit regression of PBMC gene expression with age of the patients. Dot plots represent the rel. expression of AIM2 (a), NLRP3 (b), ASC
(c), CASP1 (d), CASP5 (e) and IL1B (f) normalized to the mean rel. expression of three reference genes (GAPDH, B2M, ACTB) in PBMC in relation to
the age of the patient. Further details are described in materials and methods of the online data supplements
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with an aortic dissection (data not shown). Western blot-
ting of PBMC lysates showed cleaved, active caspase-1
(p10) together with pro-Caspase-1 (p50) in all samples (Ex-
ample in Fig. 2a). Neither the IL-1β plasma levels nor the
ratio of Caspase-1 p10/p10 + p50, indicating relative
activity of the inflammasome complex, were associated
with age (data not shown).
To adjust for vascular diseases, such as atherosclerosis,
that might interfere with inflammasome activation [12, 15],
inflammasome gene expression and activities in the group
of patients with advanced atherosclerosis (carotid stenosis,
peripheral artery disease and arterial stenosis; n = 39) were
compared with those derived from patients with other vas-
cular disease (aortic aneurysms, other; n = 38). As shown
in Fig. 2, AIM2, NLRP3, ASC, CASP1, and CASP5 gene ex-
pressions did not differ between the groups (Fig. 2b-f). In
contrast, IL1B gene expression was significantly higher in
the control group compared to the atherosclerosis group
(P = 0.0005; Fig. 2g and Additional file 1: Table S1). This
unexpected finding may be ascribed to the composition of
the control group which contained many samples from pa-
tients with aortic aneurysms. Locally increased gene






95 % CI P-value
AIM2 0.245 0.074 0.094 - 0.369 0.032
NLRP3 0.367 0.054 0.254 - 0.477 0.001
ASC(PYCARDN 0.252 0.080 0.114 - 0.412 0.027
CASP1 0.296 0.089 0.116 - 0.483 0.009
CASP5 0.453 0.069 0.320 - 0.570 0.00003
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Fig. 2 a Examples of a western blot showing expression of Pro-Caspase-1 and its cleavage products in PBMC from five different patients,
and comparison of the p10/(p10 + p50) ratios according to vascular disease. Twenty μg of each PBMC lysate was loaded per lane. Details
for detection are described in the Additional file 2. b to g Comparison of inflammasome gene expression in PBMC according to vascular disease. Gene
expressions in PBMC of patients with advanced atherosclerosis (carotid stenosis, peripheral artery disease) were compared with PBMC gene expression
in patients with other vascular diseases. Details of patients characteristics are described in materials and methods of the online data supplements
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expression of IL1B is known to be increased in AAA tissue
samples [16]. Whether PBMC from AAA-patients do also
express increased levels of IL1B and other inflammasome
components is currently under our investigation and will
be published in a separate study. No difference in the rela-
tive levels of active Caspase-1 (p10) could be detected be-
tween the groups (Fig. 2a and Additional file 1: Table S1).
Despite some indications from animal experiments
[17], it is currently unknown, whether systemic inflam-
masome activation is associated with human ageing. Our
data present clear evidence for this hypothesis by demon-
strating, that gene expression of AIM2, NLRP3, ASC,
CASP1, CASP5, and IL1B in PBMC of vascular patients in-
creases with age. Future studies on inflammasome gene ex-
pression of PBMC in healthy people of different ages will
be necessary to demonstrate whether this phenomenon ap-
plies to ageing in general, although the definition of
“healthy” might be difficult in individuals above 70 years.
Regardless of the limitation to vascular patients, our
findings reinforce results from previous studies, describ-
ing age-associated mechanisms that are required for
priming of inflammasome components. For example,
constitutive transcriptional activity of NF-κB, which is
necessary for induction of NLRP3 and IL1B gene expres-
sion, has been demonstrated in aged tissues and organ-
isms [18–20]. In addition, increased levels of the AIM2
protein in human fibroblasts were associated with senes-
cence and increased production of IL-1β [21].
Since phase-1 activation was not accompanied by in-
creased IL-1β and Caspase-p10 levels in our study, we
conclude that full inflammasome assembly and activa-
tion, requiring a second signal [10], do not occur with a
higher frequency in PBMC of the elderly. This is in line
with previous reports, demonstrating that PBMC of
young and older individuals do not differ in Il-1β release
after stimulation with LPS in vitro [4].
Instead, our data point to an age-associated shift towards
a preactivated first line of defense by innate immunity.
Given a systemic increase in priming of inflammasome
genes through constitutive gene expression in PBMC with
ageing, the threshold for full inflammasome activation by
the second signal derived from local DAMP recognition in
different tissues might be reached earlier and predispose
individuals to vascular and other chronic diseases. Cum-
mulative evidence supports the existence of such age-
associated changes in the cellular components of the
innate immune system [2, 4]. However, as yet, we cannot
deduce from our data, whether the increased inflamma-
some gene expression results from a general activation
across all PBMC or from an altered PBMC composition,
i.e. an increase in monocyte numbers, as reported previ-
ously [22]. Further investigations, addressing this question
are currently under examination. In addition, our ongoing
studies aim to elucidate the interaction of primed PBMC
with vascular tissues and their impact on vascular disease
progression. The reason for the increased gene expression
of inflammasome components in PBMC during ageing is
unknown so far. Besides DAMPS and pathogens serving
as immunomodulators, the sympathethic nervous system
was recently described to affect the functions of both in-
nate and adaptive immune cells via the β-adrenergic re-
ceptor (β-AR) [23, 24]. It remains to be shown, whether
ageing-associated changes in β-AR function contribute to
altered inflammasome gene expression in PBMC.
In summary, the present study adds important findings
to the concept of inflammaging by demonstrating an age-
dependent increase in activation of innate immunity via
systemic priming of inflammasomes in vascular patients.
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